Showing results (101-110 of 145) with videos related to
Sort By:
Pageof 15
Alimentary Pharmacology & Therapeutics|February 19, 2024
Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in AustraliaEmily Nash, Amanda Nicoll, Nicholas Batt, et al.Alimentary Pharmacology & Therapeutics|June 19, 2025
Surviving Hepatitis C-Understanding Death and Survival Beyond CurePaul J Clark, Patricia C Valery, Simone I Strasser, et al.Transplantation Direct|April 20, 2023
The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New ZealandJess Howell, Avik Majumdar, Michael Fink, et al.Hepatology Communications|July 19, 2021
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Mazen Noureddin, et al.Scandinavian Journal of Gastroenterology|May 11, 2016
Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world studyAdam Doyle, Philip Marsh, Raghubinder Gill, et al.Alimentary Pharmacology & Therapeutics|April 12, 2019
Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levelsAmanda J Nicoll, Stuart K Roberts, Ricky Lim, et al.Journal of Gastroenterology and Hepatology|December 19, 2023
Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of carePaul J Clark, Patricia C Valery, Simone I Strasser, et al.Alimentary Pharmacology & Therapeutics|August 22, 2025
Long-Term Follow-Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg LossSimon J Hume, Samuel Hall, Gareth Burns, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 8, 2021
Turning the Tide on Hepatitis C Virus-Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New ZealandJess Howell, Avik Majumdar, Michael A Fink, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 22, 2024
Incidence, epidemiology, and outcomes of acute allograft rejection following liver transplantation in AustraliaLauren C Y Tang, John D Chetwood, Mandy S M Lai, et al.Pageof 15